207 related articles for article (PubMed ID: 28502135)
21. Interleukin (IL)-10, IL-1ra and IL-12 profiles in active and quiescent systemic lupus erythematosus: could longitudinal studies reveal patient subgroups of differing pathology?
Capper ER; Maskill JK; Gordon C; Blakemore AI
Clin Exp Immunol; 2004 Nov; 138(2):348-56. PubMed ID: 15498048
[TBL] [Abstract][Full Text] [Related]
22. Elevated serum interleukin-15 levels in systemic lupus erythematosus.
Park YB; Kim DS; Lee WK; Suh CH; Lee SK
Yonsei Med J; 1999 Aug; 40(4):343-8. PubMed ID: 10487137
[TBL] [Abstract][Full Text] [Related]
23. Impact of heart rate variability, a marker for cardiac health, on lupus disease activity.
Thanou A; Stavrakis S; Dyer JW; Munroe ME; James JA; Merrill JT
Arthritis Res Ther; 2016 Sep; 18(1):197. PubMed ID: 27590046
[TBL] [Abstract][Full Text] [Related]
24. Gene expression of cytokines (TNF-α, IFN-γ), serum profiles of IL-17 and IL-23 in paediatric systemic lupus erythematosus.
Rana A; Minz RW; Aggarwal R; Anand S; Pasricha N; Singh S
Lupus; 2012 Sep; 21(10):1105-12. PubMed ID: 22759859
[TBL] [Abstract][Full Text] [Related]
25. Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosus.
Robak E; Smolewski P; Wozniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
Eur Cytokine Netw; 2004; 15(3):222-30. PubMed ID: 15542447
[TBL] [Abstract][Full Text] [Related]
26. Th1/Th2 cytokine profile in childhood-onset systemic lupus erythematosus.
Postal M; Peliçari KO; Sinicato NA; Marini R; Costallat LT; Appenzeller S
Cytokine; 2013 Mar; 61(3):785-91. PubMed ID: 23332615
[TBL] [Abstract][Full Text] [Related]
27. Apoptosis in patients with primary antiphospholipid antibody syndrome.
Tang KT; Hsieh TY; Chao YH; Li JP; Lan JL; Lin CC; Chen DY
Int J Rheum Dis; 2019 Apr; 22(4):677-685. PubMed ID: 30729698
[TBL] [Abstract][Full Text] [Related]
28. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
Gabay C; Cakir N; Moral F; Roux-Lombard P; Meyer O; Dayer JM; Vischer T; Yazici H; Guerne PA
J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987
[TBL] [Abstract][Full Text] [Related]
29. Interleukin 1, interleukin 6, interleukin 10, and tumor necrosis factor α in active and quiescent systemic lupus erythematosus.
Cigni A; Pileri PV; Faedda R; Gallo P; Sini A; Satta AE; Marras R; Carta E; Argiolas D; Rum I; Masala A
J Investig Med; 2014 Jun; 62(5):825-9. PubMed ID: 24987977
[TBL] [Abstract][Full Text] [Related]
30. Serum and urine interleukin-17A levels as biomarkers of disease activity in systemic lupus erythematosus.
Nordin F; Shaharir SS; Abdul Wahab A; Mustafar R; Abdul Gafor AH; Mohamed Said MS; Rajalingham S; Shah SA
Int J Rheum Dis; 2019 Aug; 22(8):1419-1426. PubMed ID: 31179646
[TBL] [Abstract][Full Text] [Related]
31. Increased serum IL-36α and IL-36γ levels in patients with systemic lupus erythematosus: Association with disease activity and arthritis.
Mai SZ; Li CJ; Xie XY; Xiong H; Xu M; Zeng FQ; Guo Q; Han YF
Int Immunopharmacol; 2018 May; 58():103-108. PubMed ID: 29571080
[TBL] [Abstract][Full Text] [Related]
32. Melatonin Receptor 1β Gene Polymorphism rs10830963, Serum Melatonin, TNF-α, IL-6, IL-1β, in Egyptian Patients with Systemic Lupus Erythematosus.
Fayad A; Hassan E; Salem T
Egypt J Immunol; 2019 Jan; 26(1):101-112. PubMed ID: 31333000
[TBL] [Abstract][Full Text] [Related]
33. Profiles of cytokines (TNF alpha and IL-6) and acute phase proteins (CRP and alpha 1AG) related to the disease course in patients with systemic lupus erythematosus.
Meijer C; Huysen V; Smeenk RT; Swaak AJ
Lupus; 1993 Dec; 2(6):359-65. PubMed ID: 7511020
[TBL] [Abstract][Full Text] [Related]
34. Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus.
Aderka D; Wysenbeek A; Engelmann H; Cope AP; Brennan F; Molad Y; Hornik V; Levo Y; Maini RN; Feldmann M
Arthritis Rheum; 1993 Aug; 36(8):1111-20. PubMed ID: 8393677
[TBL] [Abstract][Full Text] [Related]
35. The effect of acute physical exercise on cytokine levels in patients with systemic lupus erythematosus.
da Silva AE; dos Reis-Neto ET; da Silva NP; Sato EI
Lupus; 2013 Dec; 22(14):1479-83. PubMed ID: 24135080
[TBL] [Abstract][Full Text] [Related]
36. Peripheral blood lymphocyte apoptosis and circulating dendritic cells in patients with systemic lupus erythematosus: correlation with immunological status and disease-related symptoms.
Robak E; Sysa-Jedrzejowska A; Robak T; Smolewski P
Clin Rheumatol; 2006 Mar; 25(2):225-33. PubMed ID: 16432661
[TBL] [Abstract][Full Text] [Related]
37. Raised serum level of APRIL in patients with systemic lupus erythematosus: correlations with disease activity indices.
Hegazy M; Darwish H; Darweesh H; El-Shehaby A; Emad Y
Clin Immunol; 2010 Apr; 135(1):118-24. PubMed ID: 20116334
[TBL] [Abstract][Full Text] [Related]
38. Increased IL-18 in patients with systemic lupus erythematosus: relations with Th-1, Th-2, pro-inflammatory cytokines and disease activity. IL-18 is a marker of disease activity but does not correlate with pro-inflammatory cytokines.
Amerio P; Frezzolini A; Abeni D; Teofoli P; Girardelli CR; De Pità O; Puddu P
Clin Exp Rheumatol; 2002; 20(4):535-8. PubMed ID: 12175109
[TBL] [Abstract][Full Text] [Related]
39. Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
Petri MA; van Vollenhoven RF; Buyon J; Levy RA; Navarra SV; Cervera R; Zhong ZJ; Freimuth WW;
Arthritis Rheum; 2013 Aug; 65(8):2143-53. PubMed ID: 23754628
[TBL] [Abstract][Full Text] [Related]
40. [Tumor necrosis factor-related apoptosis-inducing ligand gene polymorphism and its plasma phenotype in relation to Crohn's disease].
Zhu HQ; Hu P; Xu F; Shao XX; Cao SG; Wu H; Jiang Y
Zhonghua Yi Xue Za Zhi; 2023 Feb; 103(8):585-593. PubMed ID: 36822870
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
